Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome

doi:10.3748/wjg.v26.i24.3472

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7603)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

431

WORD

164

HTML

3459

Figures (1-2)

366

Tables (1-4)

295

Sum=4715

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

856

Download

2032

Sum=2888

Jun 28, 2020 (publication date) through Jan 18, 2025

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Jun 28, 2020; 26(24): 3472-3483
Published online Jun 28, 2020. doi: 10.3748/wjg.v26.i24.3472

Full Size Figure Download Figure

Figure 1 Kaplan-Meier survival curves for patients in the transjugular intrahepatic portosystemic shunting and conservative treatment groups. Survival was significantly longer in the transjugular intrahepatic portosystemic shunting group than in the conservative treatment group (P < 0.001, log-rank test). TIPS: Transjugular intrahepatic portosystemic shunting.

Citation: Zhou CZ, Wang RF, Lv WF, Fu YQ, Cheng DL, Zhu YJ, Hou CL, Ye XJ. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome. World J Gastroenterol 2020; 26(24): 3472-3483
URL: https://www.wjgnet.com/1007-9327/full/v26/i24/3472.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i24.3472